Your browser doesn't support javascript.
loading
Response to immune checkpoint inhibitor rechallenge after high-grade immune related adverse events in patients with advanced melanoma.
Shah, Payal; Punekar, Salman R; Pavlick, Anna C.
Affiliation
  • Shah P; Department of Medical Oncology, New York University School of Medicine, New York, USA.
Melanoma Res ; 31(3): 242-248, 2021 06 01.
Article in En | MEDLINE | ID: mdl-33741813
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immune Checkpoint Inhibitors / Melanoma Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Melanoma Res Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immune Checkpoint Inhibitors / Melanoma Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Melanoma Res Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication: